Epidermal growth factor receptor (EGFR) is a member of the ErbB family of RTKs, and like MET, has been implicated in NSCLC development and activation of pathways that mediate cell proliferation and survival [144,145]. This evidence concerns the gene MET and non-small cell lung carcinoma.